---
permalink: /
title: ""
excerpt: ""
author_profile: true
redirect_from: 
  - /about/
  - /about.html
---

{% if site.google_scholar_stats_use_cdn %}
{% assign gsDataBaseUrl = "https://cdn.jsdelivr.net/gh/" | append: site.repository | append: "@" %}
{% else %}
{% assign gsDataBaseUrl = "https://raw.githubusercontent.com/" | append: site.repository | append: "/" %}
{% endif %}
{% assign url = gsDataBaseUrl | append: "google-scholar-stats/gs_data_shieldsio.json" %}

<span class='anchor' id='about-me'></span>

I'm **Meiping Xiong <font face="Ê•∑‰Ωì" >(ÁÜäÁæéËêç)</font>**, a Ph.D. candidate in School of Pharmaceutical Sciences, Peking University, advised by [Prof. Xianchan Li](https://dpa.bjmu.edu.cn/gbenglish/Faculty2022/Professor/2aba88aca18b4ad39b1eb00785a138f1.htm). I received my B.S. degree from West China School of Pharmacy, Sichuan University, China. My research interests include drug analysis, neurobioelectric analysis, and regulatory mechanisms of neurodegenerative diseases. 

# üî• News

- *2025.12*: Created a new home page. 

# üìù Selected Publications 

<div class='paper-box'><div class='paper-box-image'><div><div class="badge">Pharmacological Research 2021</div><img src='images/Treatment_of_melanoma.jpg' alt="sym" width="100%"></div></div>
<div class='paper-box-text' markdown="1">
[Repurposing of antipsychotic trifluoperazine for treating brain metastasis, lung metastasis and bone metastasis of melanoma by disrupting autophagy flux](https://www.sciencedirect.com/science/article/abs/pii/S1043661820316030) 

Yong Xia, Fuyan Xu, **Meiping Xiong**, Hao Yang, Wentao Lin, Yao Xie, Huizhi Xi, Qiang Xue, Tinghong Ye, Luoting Yu

Pharmacological Research,  
A novel therapeutic strategy for suppressing melanoma progression via autophagy disruption.
</div>
</div>


- More papers are being submitted, or please visit my [Google Scholar](https://scholar.google.com/citations?user=DRr5OegAAAAJ) to view all papers.

# üéñ Honors and Awards
- *2020.12* **China National Scholarship**, Ministry of Education of the People‚Äôs Republic of China (<strong><font color=red>Top 1.5%</font></strong>), NEU.
- *2019.12* **China National Scholarship**, Ministry of Education of the People‚Äôs Republic of China (<strong><font color=red>Top 1.5%</font></strong>), NEU.
- *2018.12* **China National Scholarship**, Ministry of Education of the People‚Äôs Republic of China (<strong><font color=red>Top 1.5%</font></strong>), NEU.


# üìñ Educations
- *2025.09 - 2029.06 (excepted)*,  
School of Pharmaceutical Sciences, Peking University, China.  
Ph.D. Candidate
- *2022.09 - 2025.06*,  
School of Pharmaceutical Sciences, Peking University, China.  
Master of Pharmacy 
- *2017.09 - 2022.06*,  
West China School of Pharmacy, Sichuan University, China.  
Bachelor of Clinical Pharmacy

# üî¨ Research Experience

- *2022 ‚Äì Present*, 
Quantitative Analysis of Acetylcholine Release from Single Neuronal Vesicles using Liquid-Liquid Interface Electrodes **(Project Leader)**
- *2020 ‚Äì 2021*, 
Mechanism of Trifluoperazine Hydrochloride against Melanoma and its Metastasis **(Core Member)**
- *2020 ‚Äì 2021*,
Exploration and Implementation of Voriconazole TDM Pharmaceutical Care Model based on Precision Medicine **(Core Member)**
- *2021 ‚Äì 2022*,
Epilepsy Patient Follow-up Database Management (Dept. of Neurology, West China Hospital, **Key Member**)

# üè• Internship Experience
